TheEdgeResearch
Home / Stocks / PEG.CO

Pharma Equity Group A/S (PEG.CO)

CPH Healthcare Biotechnology
$0.09 ▼ -2.43%
Market Cap
$108.3M
Sector
Healthcare
Industry
Biotechnology
Beta
1.00
52-Wk Range
0.0602-0.15
CEO
Christian Henrik Tange
Country
DK
Currency
DKK

Pharma Equity Group A/S operates in the Biotechnology industry of the Healthcare sector, headquartered in Horsholm, CR, DK. The stock last traded at $0.09, down 2.43% on the session, giving a market capitalisation of $108.3M. Its beta of 1.00 implies it has historically moved more than the broad market.

Company profile
Exchange
NASDAQ Copenhagen
Employees
5
IPO date
2023-05-16
Headquarters
Horsholm, CR, DK
About Pharma Equity Group A/S

Operating from Hørsholm, Denmark, Pharma Equity Group A/S is an investment firm primarily focused on the life sciences industry. The company strategically provides early-stage capital to ventures that are developing advanced technologies and treatments designed to improve human health and elevate the quality of life.

Comparable companies

Pharma Equity Group A/S is most often compared with the following Healthcare names:

BRAINP.COMONSO.COSMSMED.COSTENO.COVIRO.CO
More research on PEG.CO
PEG.CO technical analysis PEG.CO TheEdge Score Compare against peers
Open full interactive analysis & DCF →